Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Offerpad Soln Inc (Class A) | Roberto Sella | Director | 29 Mar 2023 | 44,195,302 | 45,573,408 | - | 0.0 | 4,420 | Class A Common Stock | |
| Offerpad Soln Inc (Class A) | Roberto Sella | Director | 29 Mar 2023 | 44,195,302 | 0 | - | - | Warrants | ||
| Walmart | Jim. C. Walton | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 144.06 per share. | 29 Mar 2023 | 1,640,457 | 247,483,429 (8%) | 0% | 144.1 | 236,319,806 | Common Stock |
| Walmart | S. Robson Walton | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 144.06 per share. | 29 Mar 2023 | 1,640,457 | 247,483,429 (8%) | 0% | 144.1 | 236,319,806 | Common Stock |
| Walmart | Alice L. Walton | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 144.06 per share. | 29 Mar 2023 | 1,640,457 | 247,483,429 (8%) | 0% | 144.1 | 236,319,806 | Common Stock |
| Sarcos Tech and Robotics Corp | Kiva A. Allgood | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 1,479,290 | 1,479,290 | - | - | Stock Option (right to buy) | |
| Walmart | Jim. C. Walton | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 145.49 per share. | 29 Mar 2023 | 1,458,353 | 245,757,202 (8%) | 0% | 145.5 | 212,168,778 | Common Stock |
| Walmart | S. Robson Walton | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 145.49 per share. | 29 Mar 2023 | 1,458,353 | 245,757,202 (8%) | 0% | 145.5 | 212,168,778 | Common Stock |
| Walmart | Alice L. Walton | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 145.49 per share. | 29 Mar 2023 | 1,458,353 | 245,757,202 (8%) | 0% | 145.5 | 212,168,778 | Common Stock |
| Faraday Future Intelligent Electric Inc (Class A) | Xuefeng Chen | Director, Global Chief Exec. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 1,000,000 | 1,000,000 | - | - | Performance Stock Options (Right to Buy) | |
| Sarcos Tech and Robotics Corp | Kiva A. Allgood | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 964,010 | 1,557,006 | - | 0 | Common Stock | |
| CXApp Inc (Class A) | Khurram P. Sheikh | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 844,200 | 844,200 | - | - | Stock Options | |
| Beyond Air Inc | Steven A. Lisi | Director, CEO and Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 800,000 | 800,000 | - | - | Stock Option (right to buy) | |
| Faraday Future Intelligent Electric Inc (Class A) | Yueting Jia | Fndr, Chief P&U Ecosys Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 565,211 | 565,211 | - | - | Performance Stock Options (Right to Buy) | |
| Faraday Future Intelligent Electric Inc (Class A) | Yun Han | CAO & Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 517,241 | 517,241 | - | - | Performance Stock Units | |
| Assembly Biosciences Inc | Jason A. Okazaki | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 470,000 | 470,000 | - | - | Stock Option (right to buy) | |
| Sarcos Tech and Robotics Corp | Andrew D. Hamer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 410,914 | 410,914 | - | - | Stock Option (right to buy) | |
| Sarcos Tech and Robotics Corp | Denis Garagic | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 410,914 | 410,914 | - | - | Stock Option (right to buy) | |
| Liberty Broadband Corp - Ordinary Shares - Series A | John C. Malone | Director, Ten Percent Owner | 29 Mar 2023 | 400,000 | 400,000 | - | - | Put option (right to sell) | ||
| Liberty Broadband Corp - Ordinary Shares - Series A | John C. Malone | Director, Ten Percent Owner | 29 Mar 2023 | 400,000 | 400,000 | - | - | Call option(obligation to sell) | ||
| Liberty Broadband Corp - Ordinary Shares - Series A | John C. Malone | Director, Ten Percent Owner | 29 Mar 2023 | 400,000 | 0 | - | - | Put option (right to sell) | ||
| Liberty Broadband Corp - Ordinary Shares - Series A | John C. Malone | Director, Ten Percent Owner | 29 Mar 2023 | 400,000 | 0 | - | - | Call option(obligation to sell) | ||
| N2OFF Inc | David Palach | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 300,000 | 300,000 | - | 0 | Restricted Shares of Common Stock | |
| Sarcos Tech and Robotics Corp | Kristi Martindale | EVP, Ch. Product & Market Off | 29 Mar 2023 | 284,352 | 284,352 | - | - | Stock Option (right to buy) | ||
| Sarcos Tech and Robotics Corp | Jorgen Pedersen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 284,352 | 284,352 | - | - | Stock Option (Right to Buy) | |
| Walmart | Jim. C. Walton | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 144.70 per share. | 29 Mar 2023 | 267,874 | 247,215,555 (8%) | 0% | 144.7 | 38,760,618 | Common Stock |
| Walmart | S. Robson Walton | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 144.70 per share. | 29 Mar 2023 | 267,874 | 247,215,555 (8%) | 0% | 144.7 | 38,760,618 | Common Stock |
| Walmart | Alice L. Walton | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 144.70 per share. | 29 Mar 2023 | 267,874 | 247,215,555 (8%) | 0% | 144.7 | 38,760,618 | Common Stock |
| Sarcos Tech and Robotics Corp | Andrew D. Hamer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 267,781 | 908,807 | - | 0 | Common Stock | |
| Sarcos Tech and Robotics Corp | Denis Garagic | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 267,781 | 321,693 | - | 0 | Common Stock | |
| Beyond Air Inc | Amir Avniel | Director, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 240,000 | 697,027 (4%) | 1% | 0 | Common Stock | |
| McCormick & Company | Lawrence E. Kurzius | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 222,223 | 222,223 | - | - | Options- Right to Buy | |
| Fastly Inc (Class A) | Todd Nightingale | Director, CEO | 29 Mar 2023 | 218,871 | 1,402,420 (1%) | 0% | 0 | Class A Common Stock | ||
| Taboola.com Ltd | Adam Singolda | Director, Founder and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.52 per share. | 29 Mar 2023 | 206,203 | 11,876,919 | - | 2.5 | 519,632 | Ordinary Shares |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 200,280 | 5,934 | - | - | Employee Stock Option | |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 224.85 per share. | 29 Mar 2023 | 200,280 | 3,083,303 (5%) | 0% | 224.9 | 45,032,958 | Common Stock |
| Sarcos Tech and Robotics Corp | Kristi Martindale | EVP, Ch. Product & Market Off | 29 Mar 2023 | 185,304 | 291,476 | - | 0 | Common Stock | ||
| Sarcos Tech and Robotics Corp | Jorgen Pedersen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 185,304 | 7,103,628 | - | 0 | Common Stock | |
| Sprout Social Inc (Class A) | Ryan Barretto | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 180,134 | 491,042 (1%) | 0% | 0 | Class A Common Stock | |
| Blend Labs Inc (Class A) | Nima Ghamsari | Director, Head of Blend | Other type of transaction at price $ 0.00 per share. | 29 Mar 2023 | 169,242 | 169,242 | - | 0 | Class A Common Stock | |
| Blend Labs Inc (Class A) | Nima Ghamsari | Director, Head of Blend | Other type of transaction at price $ 0.00 per share. | 29 Mar 2023 | 169,242 | 10,051,351 | - | - | Class B Common Stock | |
| Blend Labs Inc (Class A) | Nima Ghamsari | Director, Head of Blend | Sale of securities on an exchange or to another person at price $ 0.94 per share. | 29 Mar 2023 | 169,242 | 0 | - | 0.9 | 158,766 | Class A Common Stock |
| Mirion Tech Inc (Class A) | Thomas Logan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 167,701 | 739,433 | - | 0 | Class A Common Stock | |
| Fastly Inc (Class A) | Ronald W. Kisling | Chief Financial Officer | 29 Mar 2023 | 163,424 | 555,812 (0%) | 0% | 0 | Class A Common Stock | ||
| Faraday Future Intelligent Electric Inc (Class A) | Xuefeng Chen | Director, Global Chief Exec. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 141,300 | 141,300 | - | - | Performance Stock Options (Right to Buy) | |
| Assembly Biosciences Inc | William E. Delaney | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 140,000 | 140,000 | - | - | Stock Option (right to buy) | |
| Royalty Pharma PLC (Class A) | Rory B. Riggs | Director | 29 Mar 2023 | 130,024 | 1,456,762 | - | 36.3 | 4,714,345 | Class A Ordinary Shares | |
| Beyond Air Inc | Douglas Quinton Larson | Chief Financial Officer | 29 Mar 2023 | 120,000 | 120,000 | - | - | Stock Option (right to buy) | ||
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 216.83 per share. | 29 Mar 2023 | 116,135 | 2,914,836 (4%) | 0% | 216.8 | 25,181,552 | Common Stock |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 116,135 | 296,473 | - | - | Employee Stock Option | |
| Sprout Social Inc (Class A) | Justyn Howard | Director, Chairman and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 113,766 | 335,221 (0%) | 0% | 0 | Class A Common Stock | |
| CompoSecure Inc (Class A) | Donald G. Basile | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 Mar 2023 | 112,543 | 10,517,700 | - | - | Warrant | |
| CompoSecure Inc (Class A) | Dixon R. Doll | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 Mar 2023 | 112,543 | 10,517,700 | - | - | Warrant | |
| Fastly Inc (Class A) | Brett Shirk | Executive Vice President, CRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 108,949 | 325,184 (0%) | 0% | 0 | Class A Common Stock | |
| Aeva Tech Inc | Saurabh Sinha | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 108,020 | 958,607 | - | - | Restricted Stock Units | |
| Aeva Tech Inc | Saurabh Sinha | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 108,020 | 1,162,150 | - | - | Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Jason Kelly | Director, See remarks | Sale of securities on an exchange or to another person at price $ 1.24 per share. | 29 Mar 2023 | 100,000 | 11,694,680 | - | 1.2 | 124,400 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Jason Kelly | Director, See remarks | Sale of securities on an exchange or to another person at price $ 1.24 per share. | 29 Mar 2023 | 100,000 | 11,794,680 | - | 1.2 | 123,500 | Class A Common Stock |
| N2OFF Inc | Lital Barda | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 100,000 | 100,000 | - | 0 | Restricted Shares of Common Stock | |
| Tradeweb Markets Inc - Ordinary Shares Cls A | Lee Olesky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 95,070 | 458,183 | - | - | Stock Option (Right to Buy) | |
| Tradeweb Markets Inc - Ordinary Shares Cls A | Lee Olesky | Director | Sale of securities on an exchange or to another person at price $ 78.12 per share. | 29 Mar 2023 | 95,070 | 283,202 (0%) | 0% | 78.1 | 7,426,954 | Class A common stock |
| Tradeweb Markets Inc - Ordinary Shares Cls A | Lee Olesky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.59 per share. | 29 Mar 2023 | 95,070 | 378,272 (0%) | 0% | 20.6 | 1,957,491 | Class A common stock |
| Kohl`s Corp | Thomas A. Kingsbury | Director, Chief Executive Officer | 29 Mar 2023 | 92,500 | 228,993 (0%) | 0% | 21.8 | 2,018,350 | Common Stock | |
| Intellicheck Inc | Jeffrey Ishmael | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 91,228 | 91,228 | - | - | Restricted Stock Units (RSUs) | |
| Intellicheck Inc | Jeffrey Ishmael | CFO | Other type of transaction at price $ 0.00 per share. | 29 Mar 2023 | 91,228 | 0 | - | - | Stock Option (Right to Buy) | |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 90,259 | 206,214 | - | - | Employee Stock Option | |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 217.70 per share. | 29 Mar 2023 | 90,259 | 2,936,454 (4%) | 0% | 217.7 | 19,649,384 | Common Stock |
| Healthequity Inc | Jon Kessler | Director, PRESIDENT AND CEO | 29 Mar 2023 | 86,179 | 262,050 (0%) | 0% | 0 | Common Stock | ||
| Beyond Air Inc | Amir Avniel | Director, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Faraday Future Intelligent Electric Inc (Class A) | Xuefeng Chen | Director, Global Chief Exec. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 70,650 | 70,650 | - | - | Performance Stock Options (Right to Buy) | |
| Faraday Future Intelligent Electric Inc (Class A) | Xuefeng Chen | Director, Global Chief Exec. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 70,650 | 70,650 | - | - | Performance Stock Options (Right to Buy) | |
| Faraday Future Intelligent Electric Inc (Class A) | Xuefeng Chen | Director, Global Chief Exec. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 70,650 | 70,650 | - | - | Performance Stock Options (Right to Buy) | |
| ATAI Life Sciences N.V. | Florian Brand | See Remarks | Purchase of securities on an exchange or from another person at price $ 1.48 per share. | 29 Mar 2023 | 70,000 | 70,000 | - | 1.5 | 103,558 | Common Shares |
| Pliant Therapeutics Inc | Bernard Coulie | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 68,749 | 310,092 | - | 0 | Common Stock | |
| Xponential Fitness Inc (Class A) | Anthony Geisler | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.26 per share. | 29 Mar 2023 | 66,200 | 873,969 | - | 30.3 | 2,003,212 | Class A Common Stock |
| McCormick & Company | Michael R. Smith | Executive VP & CFO | 29 Mar 2023 | 62,016 | 62,016 | - | - | Options - Right to Buy | ||
| McCormick & Company | Brendan M. Foley | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 62,016 | 62,016 | - | - | Options- Right to Buy | |
| Snowflake Inc (Class A) | Benoit Dageville | Director, President of Products | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 60,827 | 64,999 | - | - | Stock Option (Right to Buy) | |
| Snowflake Inc (Class A) | Benoit Dageville | Director, President of Products | Sale of securities on an exchange or to another person at price $ 136.26 per share. | 29 Mar 2023 | 60,827 | 43,063 | - | 136.3 | 8,288,287 | Class A Common Stock |
| Snowflake Inc (Class A) | Benoit Dageville | Director, President of Products | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.26 per share. | 29 Mar 2023 | 60,827 | 103,890 | - | 0.3 | 15,815 | Class A Common Stock |
| Aeva Tech Inc | Saurabh Sinha | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.15 per share. | 29 Mar 2023 | 57,977 | 1,104,173 | - | 1.2 | 66,674 | Common Stock |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 217.28 per share. | 29 Mar 2023 | 54,913 | 2,859,923 (4%) | 0% | 217.3 | 11,931,700 | Common Stock |
| Mirion Tech Inc (Class A) | Brian Schopfer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 49,689 | 166,984 | - | 0 | Class A Common Stock | |
| Tradeweb Markets Inc - Ordinary Shares Cls A | Lee Olesky | Director | Sale of securities on an exchange or to another person at price $ 77.11 per share. | 29 Mar 2023 | 48,170 | 235,032 (0%) | 0% | 77.1 | 3,714,586 | Class A common stock |
| Walmart | Jim. C. Walton | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 146.25 per share. | 29 Mar 2023 | 45,686 | 245,711,516 (8%) | 0% | 146.2 | 6,681,472 | Common Stock |
| Walmart | S. Robson Walton | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 146.25 per share. | 29 Mar 2023 | 45,686 | 245,711,516 (8%) | 0% | 146.2 | 6,681,472 | Common Stock |
| Walmart | Alice L. Walton | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 146.25 per share. | 29 Mar 2023 | 45,686 | 245,711,516 (8%) | 0% | 146.2 | 6,681,472 | Common Stock |
| Bluelinx Hldgs Inc | Dwight A.K. Gibson | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 44,160 | 76,118 (0%) | 0% | - | Common Stock | |
| McCormick & Company | Malcolm Swift | President, Global Flavor Sol | 29 Mar 2023 | 43,928 | 43,928 | - | - | Options - Right to Buy | ||
| McCormick & Company | Jeffery D. Schwartz | Vice President, Gen Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 43,928 | 43,928 | - | - | Options - Right to Buy | |
| Xponential Fitness Inc (Class A) | Anthony Geisler | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.54 per share. | 29 Mar 2023 | 43,592 | 804,714 | - | 31.5 | 1,374,892 | Class A Common Stock |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 224.92 per share. | 29 Mar 2023 | 43,356 | 2,994,698 (5%) | 0% | 224.9 | 9,751,484 | Common Stock |
| Gogo Inc | Oakleigh Thorne | Director, CEO and Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 43,017 | 86,034 | - | - | Restricted Stock Units | |
| Gogo Inc | Oakleigh Thorne | Director, CEO and Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 43,017 | 557,175 (0%) | 0% | - | Common Stock | |
| Mirion Tech Inc (Class A) | Michael Rossi | Medical Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 41,242 | 121,687 | - | 0 | Class A Common Stock | |
| Outlook Therapeutics Inc | Kurt J. Hilzinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 41,065 | 41,065 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Ralph H. Thurman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 41,065 | 41,065 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Julian S. Gangolli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 41,065 | 41,065 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Gerd U. Auffarth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 41,065 | 41,065 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 41,065 | 41,065 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Faisal G. Sukhtian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 41,065 | 41,065 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Yezan Munther Haddadin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 41,065 | 41,065 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Andong Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 41,065 | 41,065 | - | - | Stock Option (Right to Buy) | |
| BioAtla Inc | Jay M. Short | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.47 per share. | 29 Mar 2023 | 40,800 | 1,412,387 | - | 2.5 | 100,862 | Common Stock |
| Sprout Social Inc (Class A) | Del Joseph Preto | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 40,631 | 149,522 (0%) | 0% | 0 | Class A Common Stock | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 40,000 | 987,155 | - | - | Stock Option (Right to Buy) | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 40,000 | 1,027,155 | - | - | Stock Option (Right to Buy) | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 29 Mar 2023 | 40,000 | 5,451,946 (1%) | 0% | 1.0 | 39,600 | Common Stock |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 29 Mar 2023 | 40,000 | 5,451,946 (1%) | 0% | 1.0 | 39,600 | Common Stock |
| Beyond Air Inc | William P. Forbes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Beyond Air Inc | Robert F. Carey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Beyond Air Inc | Erick J. Lucera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Beyond Air Inc | Yoori Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Xponential Fitness Inc (Class A) | Anthony Geisler | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.04 per share. | 29 Mar 2023 | 38,535 | 766,179 | - | 31.0 | 1,196,126 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Reshma P. Shetty | Director, See remarks, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.23 per share. | 29 Mar 2023 | 37,650 | 13,805,254 | - | 1.2 | 46,422 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Reshma P. Shetty | Director, See remarks, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.24 per share. | 29 Mar 2023 | 37,650 | 13,805,244 | - | 1.2 | 46,874 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Barry Canton | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.23 per share. | 29 Mar 2023 | 37,650 | 13,805,254 | - | 1.2 | 46,422 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Barry Canton | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.24 per share. | 29 Mar 2023 | 37,650 | 13,805,244 | - | 1.2 | 46,874 | Class A Common Stock |
| Snowflake Inc (Class A) | Benoit Dageville | Director, President of Products | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Mar 2023 | 35,344 | 5,120,200 | - | 0 | Class A Common Stock | |
| Alignment Healthcare Inc | John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 6.11 per share. | 29 Mar 2023 | 34,506 | 2,346,773 | - | 6.1 | 210,946 | Common Stock |
| Leidos | Roger A. Krone | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 33,920 | 33,920 | - | - | Stock Option (Right to Buy) | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 148.21 per share. | 29 Mar 2023 | 31,349 | 5,420,597 (1%) | 0% | 148.2 | 4,646,235 | Common Stock |
| Delcath Systems Inc | Gerard J. Michel | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 29 Mar 2023 | 31,110 | 31,110 | - | - | Tranche A Warrants to Purchase Common Stock | |
| Block Inc (Class A) | Alyssa Henry | Square Lead | 29 Mar 2023 | 30,769 | 0 | - | - | Class B Common Stock | ||
| Block Inc (Class A) | Alyssa Henry | Square Lead | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 30,769 | 30,769 | - | - | Class B Common Stock | |
| Block Inc (Class A) | Alyssa Henry | Square Lead | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 30,769 | 153,845 | - | - | Stock Option (right to buy) | |
| Block Inc (Class A) | Alyssa Henry | Square Lead | 29 Mar 2023 | 30,769 | 449,436 (0%) | 0% | 0 | Class A Common Stock | ||
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 30,000 | 30,000 | - | 0 | Common Stock | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 30,000 | 30,000 | - | - | Restricted Stock Units | |
| Alphabet (Class A) | John Kent Walker | President, Global Affairs, CLO | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Mar 2023 | 29,006 | 23,489 (0%) | 0% | 0 | Class C Capital Stock | |
| Alphabet (Class A) | John Kent Walker | President, Global Affairs, CLO | Sale of securities on an exchange or to another person at price $ 101.84 per share. | 29 Mar 2023 | 29,006 | 24,277 (0%) | 0% | 101.8 | 2,953,968 | Class C Capital Stock |
| Alphabet (Class A) | John Kent Walker | President, Global Affairs, CLO | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Mar 2023 | 29,006 | 53,283 (0%) | 0% | 0 | Class C Capital Stock | |
| D.R. Horton | Donald R. Horton | Director, Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Mar 2023 | 28,027 | 0 (0%) | 0% | 0 | Common Stock | |
| Universal Insurance Holdings Inc | Sean P. Downes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 27,382 | 1,365,591 (4%) | 0% | 0 | Common Stock | |
| Principal Financial Group | Roberto A. Walker | EVP, Principal Latin American | Sale or transfer of securities back to the company at price $ 72.84 per share. | 29 Mar 2023 | 26,293 | 40,290 (0%) | 0% | 72.8 | 1,915,182 | Common Stock |
| TransUnion | Todd Skinner | President, International | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 29 Mar 2023 | 25,989 | 28,749 (0%) | 0% | 60 | 1,559,340 | Common Stock |
| TransUnion | Todd Skinner | President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.57 per share. | 29 Mar 2023 | 25,989 | 54,738 (0%) | 0% | 8.6 | 222,726 | Common Stock |
| TransUnion | Todd Skinner | President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 25,989 | 11,880 | - | - | Stock Options (right to buy) | |
| Healthequity Inc | Elimelech Rosner | EVP, CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 25,725 | 85,205 (0%) | 0% | 0 | Common Stock | |
| Xponential Fitness Inc (Class A) | Anthony Geisler | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.97 per share. | 29 Mar 2023 | 25,663 | 848,306 | - | 31.0 | 794,783 | Class A Common Stock |
| CRISPR Therapeutics AG | Samarth Kulkarni | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.12 per share. | 29 Mar 2023 | 25,000 | 412,377 (0%) | 0% | 19.1 | 478,000 | Common Shares |
| CRISPR Therapeutics AG | Samarth Kulkarni | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 25,000 | 129,582 | - | - | Stock Option (Right to Buy) | |
| Achieve Life Sciences Inc | Thomas Braxton King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 24,000 | 24,000 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc | Thomas Sellig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 24,000 | 24,000 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc | Stuart Duty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 24,000 | 24,000 | - | - | Stock Option (right to buy) | |
| Healthequity Inc | Tyson Murdock | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 23,581 | 72,337 (0%) | 0% | 0 | Common Stock | |
| Achieve Life Sciences Inc | Thomas Sellig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 23,250 | 23,250 | - | - | Stock Option (right to buy) | |
| Tradeweb Markets Inc - Ordinary Shares Cls A | Lee Olesky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 22,325 | 435,858 | - | - | Stock Option (Right to Buy) | |
| Tradeweb Markets Inc - Ordinary Shares Cls A | Lee Olesky | Director | Sale of securities on an exchange or to another person at price $ 78.84 per share. | 29 Mar 2023 | 22,325 | 234,357 (0%) | 0% | 78.8 | 1,760,119 | Class A common stock |
| Tradeweb Markets Inc - Ordinary Shares Cls A | Lee Olesky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.59 per share. | 29 Mar 2023 | 22,325 | 256,682 (0%) | 0% | 20.6 | 459,672 | Class A common stock |
| Gogo Inc | Oakleigh Thorne | Director, CEO and Chairman, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.98 per share. | 29 Mar 2023 | 21,960 | 535,215 (0%) | 0% | 14.0 | 307,001 | Common Stock |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | 29 Mar 2023 | 21,874 | 157,031 | - | 0 | Common Stock | ||
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 217.66 per share. | 29 Mar 2023 | 21,782 | 2,893,709 (4%) | 0% | 217.7 | 4,741,018 | Common Stock |
| Catalyst Pharma Inc | Carmen Jeffrey Del | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 16.70 per share. | 29 Mar 2023 | 20,983 | 7,541 (0%) | 0% | 16.7 | 350,416 | Common stock, par value $0.001 per share |
| Catalyst Pharma Inc | Carmen Jeffrey Del | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 20,983 | 690,334 | - | - | Options to purchase common stock | |
| Catalyst Pharma Inc | Carmen Jeffrey Del | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.24 per share. | 29 Mar 2023 | 20,983 | 28,524 (0%) | 0% | 2.2 | 47,002 | Common stock, par value $0.001 per share |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 216.81 per share. | 29 Mar 2023 | 20,963 | 2,915,491 (4%) | 0% | 216.8 | 4,544,952 | Common Stock |
| Etsy Inc | Joshua G. Silverman | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.62 per share. | 29 Mar 2023 | 20,850 | 128,155 (0%) | 0% | 10.6 | 221,427 | Common Stock |
| Etsy Inc | Joshua G. Silverman | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 20,850 | 1,984,250 | - | - | Employee Stock Option (Right to Buy) | |
| Southwest Gas Holdings Inc | Paul M. Daily | CEO/Centuri Group, Inc. | 29 Mar 2023 | 20,616 | 57,537 (0%) | 0% | 0 | Common Stock | ||
| Claritev Corp (Class A) | Dale A. White | Director, Chief Executive Officer | 29 Mar 2023 | 20,121 | 15,697,776 | - | 1.1 | 21,731 | Class A common stock | |
| Block Inc (Class A) | Alyssa Henry | Square Lead | Sale of securities on an exchange or to another person at price $ 66.03 per share. | 29 Mar 2023 | 20,013 | 419,231 (0%) | 0% | 66.0 | 1,321,458 | Class A Common Stock |
| TCW Strategic Income Fund Inc | Laird Landmann | PORTFOLIO MANAGER | Sale of securities on an exchange or to another person at price $ 4.76 per share. | 29 Mar 2023 | 20,000 | 445,308 (0%) | 0% | 4.8 | 95,124 | Common Stock |
| Global Water Resources Inc | Jason Thuneman | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 20,000 | 0 | - | - | Stock Appreciation Right | |
| Global Water Resources Inc | Jason Thuneman | Vice President | Sale or transfer of securities back to the company at price $ 12.50 per share. | 29 Mar 2023 | 20,000 | 23,754 (0%) | 0% | 12.5 | 250,000 | Common Stock |
| Global Water Resources Inc | Jason Thuneman | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.26 per share. | 29 Mar 2023 | 20,000 | 43,754 (0%) | 0% | 4.3 | 85,200 | Common Stock |
| Synaptogenix Inc | William S. Singer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Sotherly Hotels Inc | Andrew M. Sims | Director, Chairman | Sale of securities on an exchange or to another person at price $ 1.98 per share. | 29 Mar 2023 | 20,000 | 0 (0%) | 0% | 2.0 | 39,660 | Common Stock |
| CRISPR Therapeutics AG | Samarth Kulkarni | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 44.37 per share. | 29 Mar 2023 | 19,719 | 392,658 (0%) | 0% | 44.4 | 874,997 | Common Shares |
| Delcath Systems Inc | Gerard J. Michel | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.84 per share. | 29 Mar 2023 | 19,646 | 197,235 (0%) | 0% | 4.8 | 95,087 | Common Stock |
| McCormick & Company | Sarah Piper | Chief Human Relations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 19,380 | 19,380 | - | - | Options - Right to Buy | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 19,375 | 158,430 | - | 0 | Common Stock | |
| Southwest Gas Holdings Inc | Karen S. Haller | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 19,098 | 75,640 (0%) | 0% | 0 | Common Stock | |
| Catalyst Pharma Inc | Carmen Jeffrey Del | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 19,017 | 671,317 | - | - | Options to purchase common stock | |
| Catalyst Pharma Inc | Carmen Jeffrey Del | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 16.69 per share. | 29 Mar 2023 | 19,017 | 7,541 (0%) | 0% | 16.7 | 317,394 | Common stock, par value $0.001 per share |
| Catalyst Pharma Inc | Carmen Jeffrey Del | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.21 per share. | 29 Mar 2023 | 19,017 | 26,558 (0%) | 0% | 4.2 | 80,062 | Common stock, par value $0.001 per share |
| N-able Inc | Tim O’Brien | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.75 per share. | 29 Mar 2023 | 18,786 | 531,235 | - | 13.8 | 258,308 | Common Stock, par value $0.001 per share |
| Bluelinx Hldgs Inc | Dwight A.K. Gibson | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.94 per share. | 29 Mar 2023 | 18,339 | 57,779 (0%) | 0% | 67.9 | 1,245,952 | Common Stock |
| Gogo Inc | Sergio A. Aguirre | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 18,323 | 111,443 (0%) | 0% | - | Common Stock | |
| Gogo Inc | Sergio A. Aguirre | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 18,323 | 36,646 | - | - | Restricted Stock Units | |
| Simulations Plus Inc | Walter S. Woltosz | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 42.74 per share. | 29 Mar 2023 | 18,162 | 3,897,577 (22%) | 0% | 42.7 | 776,244 | Common Stock |
| Concrete Pumping Holdings Inc (Class A) | Bruce Young | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.86 per share. | 29 Mar 2023 | 18,033 | 2,337,587 (4%) | 0% | 6.9 | 123,706 | Common Stock |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 222.05 per share. | 29 Mar 2023 | 17,620 | 3,062,840 (5%) | 0% | 222.1 | 3,912,535 | Common Stock |
| Pliant Therapeutics Inc | Hans P. Hull | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 17,578 | 211,000 | - | 0 | Common Stock | |
| J.Jill Inc | Claire Spofford | Director, President & CEO | 29 Mar 2023 | 17,564 | 17,564 | - | - | Performance Stock Units | ||
| J.Jill Inc | Claire Spofford | Director, President & CEO | 29 Mar 2023 | 17,563 | 17,563 | - | - | Restricted Stock Units | ||
| T Stamp Inc (Class A) | Alexander Valdes | Chief Financial Officer | Other type of transaction at price $ 7.79 per share. | 29 Mar 2023 | 17,354 | 63,362 | - | 7.8 | 135,188 | Class A Common Stock |
| Delcath Systems Inc | Gerard J. Michel | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 29 Mar 2023 | 16,666 | 16,666 | - | - | Tranche B Warrants to Purchase Common Stock | |
| Mirion Tech Inc (Class A) | Loic Eloy | Industrial Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 16,645 | 179,722 | - | 0 | Class A Common Stock | |
| Cns Pharma Inc | John M. Climaco | Director, Chief Executive Officer | 29 Mar 2023 | 16,467 | 61,451 | - | - | Restricted Stock Units | ||
| Sprout Social Inc (Class A) | Aaron Rankin | Director, Chief Technology Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 16,253 | 44,812 (0%) | 0% | 0 | Class A Common Stock | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 149.39 per share. | 29 Mar 2023 | 15,965 | 5,419,102 (1%) | 0% | 149.4 | 2,385,011 | Common Stock |
| SEI Investments Co. | Alfred P. West | Director, Executive Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 56.06 per share. | 29 Mar 2023 | 15,659 | 8,568,128 (5%) | 0% | 56.1 | 877,844 | Common Stock |
| Mirion Tech Inc (Class A) | Christopher A. Moore | Chief Accounting Officer (PAO) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 15,527 | 31,016 | - | 0 | Class A Common Stock | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.36 per share. | 29 Mar 2023 | 15,414 | 14,586 | - | 33.4 | 514,211 | Common Stock |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 223.13 per share. | 29 Mar 2023 | 15,239 | 3,047,601 (5%) | 0% | 223.1 | 3,400,208 | Common Stock |
| Healthequity Inc | Stephen D. Neeleman | Director, FOUNDER AND VICE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 15,006 | 66,774 (0%) | 0% | 0 | Common Stock | |
| Healthequity Inc | Larry L Trittschuh | EVP CHIEF SECURITY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 15,006 | 42,097 (0%) | 0% | 0 | Common Stock | |
| LeonaBio Inc | Grant E. Pickering | Director | Purchase of securities on an exchange or from another person at price $ 2.47 per share. | 29 Mar 2023 | 15,000 | 25,783 | - | 2.5 | 37,050 | Common Stock |
| National Research Corp | Jona S. Raasch | COO, NRC Health | Sale of securities on an exchange or to another person at price $ 42.95 per share. | 29 Mar 2023 | 15,000 | 25,619 (0%) | 0% | 43.0 | 644,279 | Common Stock |
| Principal Financial Group | Roberto A. Walker | EVP, Principal Latin American | Grant, award, or other acquisition of securities at price $ 37.38 per share. | 29 Mar 2023 | 14,558 | 54,248 (0%) | 0% | 37.4 | 544,178 | Common Stock |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 147.13 per share. | 29 Mar 2023 | 13,900 | 5,438,046 (1%) | 0% | 147.1 | 2,045,107 | Common Stock |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 217.28 per share. | 29 Mar 2023 | 13,728 | 2,846,195 (4%) | 0% | 217.3 | 2,982,871 | Common Stock |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | 29 Mar 2023 | 13,593 | 58,540 | - | 0 | Common Stock | ||
| Best Buy | Richard M. Schulze | Ten Percent Owner, Chairman Emeritus | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Mar 2023 | 13,509 | 20,256,728 (7%) | 0% | 0 | Common Stock | |
| PTC | Blake D. Moret | Director | Sale of securities on an exchange or to another person at price $ 123.91 per share. | 29 Mar 2023 | 13,176 | 7,182,656 (6%) | 0% | 123.9 | 1,632,699 | Common Stock |
| Innovative Industrial Properties Inc | David Smith | CFO AND TREASURER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 13,080 | 13,080 | - | - | Restricted Stock Units 2023 | |
| Healthequity Inc | Stephen D. Neeleman | Director, FOUNDER AND VICE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 13,057 | 79,831 (0%) | 0% | 0 | Common Stock | |
| Gogo Inc | Karen Jackson | EVP, Chief People Exp. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 12,934 | 123,145 (0%) | 0% | - | Common Stock | |
| Gogo Inc | Karen Jackson | EVP, Chief People Exp. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 12,934 | 25,867 | - | - | Restricted Stock Units | |
| Healthequity Inc | Delano Ladd | EVP, GC & CORPORATE SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 12,862 | 49,988 (0%) | 0% | 0 | Common Stock | |
| Principal Financial Group | Roberto A. Walker | EVP, Principal Latin American | Grant, award, or other acquisition of securities at price $ 62.78 per share. | 29 Mar 2023 | 12,335 | 66,583 (0%) | 0% | 62.8 | 774,391 | Common Stock |
| Etsy Inc | Joshua G. Silverman | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 106.09 per share. | 29 Mar 2023 | 12,197 | 115,958 (0%) | 0% | 106.1 | 1,293,980 | Common Stock |
| TransUnion | Todd Skinner | President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.57 per share. | 29 Mar 2023 | 11,880 | 40,629 (0%) | 0% | 8.6 | 101,812 | Common Stock |
| TransUnion | Todd Skinner | President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 11,880 | 0 | - | - | Stock Options (right to buy) | |
| Concrete Pumping Holdings Inc (Class A) | Iain Humphries | Director, CFO and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.86 per share. | 29 Mar 2023 | 11,404 | 775,931 (1%) | 0% | 6.9 | 78,231 | Common Stock |
| Principal Financial Group | Roberto A. Walker | EVP, Principal Latin American | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 10,814 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Healthequity Inc | Delano Ladd | EVP, GC & CORPORATE SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 10,446 | 60,434 (0%) | 0% | 0 | Common Stock | |
| Block Inc (Class A) | Alyssa Henry | Square Lead | Sale of securities on an exchange or to another person at price $ 65.05 per share. | 29 Mar 2023 | 10,192 | 439,244 (0%) | 0% | 65.1 | 662,990 | Class A Common Stock |
| Kayne Anderson Energy infra Fund Inc | James C. Baker | Director, President | Purchase of securities on an exchange or from another person at price $ 8.39 per share. | 29 Mar 2023 | 10,000 | 374,424 (0%) | 0% | 8.4 | 83,900 | Common Stock |
| McCormick & Company | Margaret M.V. Preston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.80 per share. | 29 Mar 2023 | 10,000 | 95,436 (1%) | 0% | 35.8 | 358,000 | Common Stock - Voting |
| McCormick & Company | Margaret M.V. Preston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 10,000 | 0 | - | - | Options- Right to Buy | |
| Universal Insurance Holdings Inc | Sean P. Downes | Director | Sale of securities on an exchange or to another person at price $ 18.37 per share. | 29 Mar 2023 | 10,000 | 1,338,209 (4%) | 0% | 18.4 | 183,693 | Common Stock |
| Universal Insurance Holdings Inc | Sean P. Downes | Director | Sale of securities on an exchange or to another person at price $ 18.83 per share. | 29 Mar 2023 | 10,000 | 1,348,209 (4%) | 0% | 18.8 | 188,343 | Common Stock |
| LeonaBio Inc | Grant E. Pickering | Director | Purchase of securities on an exchange or from another person at price $ 2.33 per share. | 29 Mar 2023 | 10,000 | 10,783 | - | 2.3 | 23,300 | Common Stock |
| National Research Corp | Jona S. Raasch | COO, NRC Health | Sale of securities on an exchange or to another person at price $ 44.30 per share. | 29 Mar 2023 | 10,000 | 40,619 (0%) | 0% | 44.3 | 442,983 | Common Stock |
| Sarcos Tech and Robotics Corp | Andrew D. Hamer | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.45 per share. | 29 Mar 2023 | 10,000 | 918,807 | - | 0.5 | 4,526 | Common Stock |
| Beyond Air Inc | Robert F. Carey | Director | Purchase of securities on an exchange or from another person at price $ 6.30 per share. | 29 Mar 2023 | 10,000 | 876,496 (5%) | 0% | 6.3 | 63,000 | Common Stock |
| Beyond Air Inc | Robert F. Carey | Director | Purchase of securities on an exchange or from another person at price $ 6.45 per share. | 29 Mar 2023 | 10,000 | 886,496 (6%) | 0% | 6.5 | 64,500 | Common Stock |
| Domo Inc (Class B) | Daren Thayne | CTO & EVP Engineering | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 9,931 | 207,346 (0%) | 0% | 0 | Class B Common Stock | |
| Royalty Pharma PLC (Class A) | Rory B. Riggs | Director | 29 Mar 2023 | 9,926 | 1,586,786 | - | 37.0 | 366,766 | Class A Ordinary Shares | |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 224.26 per share. | 29 Mar 2023 | 9,547 | 3,038,054 (5%) | 0% | 224.3 | 2,140,968 | Common Stock |
| Healthequity Inc | Larry L Trittschuh | EVP CHIEF SECURITY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 9,442 | 51,539 (0%) | 0% | 0 | Common Stock | |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 217.66 per share. | 29 Mar 2023 | 9,363 | 2,884,346 (4%) | 0% | 217.7 | 2,037,928 | Common Stock |
| J.Jill Inc | Mark W. Webb | EVP, CFO & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 9,225 | 9,225 | - | - | Restricted Stock Units | |
| J.Jill Inc | Mark W. Webb | EVP, CFO & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 9,224 | 9,224 | - | - | Performance Stock Units | |
| Nature`s Sunshine Products Inc | Terrence O. Moorehead | Director, Chief Executive Officer | 29 Mar 2023 | 8,850 | 433,357 (2%) | 0% | 10.2 | 90,359 | Common Shares | |
| Middlesex Water Co. | Dennis W. Doll | Director, President & CEO | 29 Mar 2023 | 8,653 | 23,593 | - | 77.6 | 671,732 | Common Stock (Restricted Stock Book Entry) | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 148.83 per share. | 29 Mar 2023 | 8,300 | 5,412,297 (1%) | 0% | 148.8 | 1,235,289 | Common Stock |
| Gogo Inc | Sergio A. Aguirre | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.98 per share. | 29 Mar 2023 | 8,039 | 103,404 (0%) | 0% | 14.0 | 112,385 | Common Stock |
| General Mills | Jonathon Nudi | Group President | 29 Mar 2023 | 8,030 | 83,048 (0%) | 0% | 85.3 | 685,190 | Common Stock | |
| General Mills | Jonathon Nudi | Group President | 29 Mar 2023 | 8,030 | 0 | - | - | Non-Qualified Stock Option (right to buy) | ||
| General Mills | Jonathon Nudi | Group President | 29 Mar 2023 | 8,030 | 91,078 (0%) | 0% | 53.7 | 431,211 | Common Stock | |
| ProFrac Holding Corp (Class A) | Matthew D. Wilks | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 12.35 per share. | 29 Mar 2023 | 8,000 | 72,076 | - | 12.4 | 98,822 | Class A common stock, par value $0.01 per share |
| United Therapeutics Corp | Martine A. Rothblatt | Director, CHAIRPERSON & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 113.08 per share. | 29 Mar 2023 | 8,000 | 8,130 (0%) | 0% | 113.1 | 904,640 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, CHAIRPERSON & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 113.08 per share. | 29 Mar 2023 | 8,000 | 8,130 (0%) | 0% | 113.1 | 904,640 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, CHAIRPERSON & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 8,000 | 176,000 | - | - | Stock Options | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, CHAIRPERSON & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 8,000 | 184,000 | - | - | Stock Options | |
| AAR Corp | Eric S. Pachapa | VP-CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.66 per share. | 29 Mar 2023 | 7,850 | 35,266 (0%) | 0% | 37.7 | 295,631 | Common Stock |
| AAR Corp | Eric S. Pachapa | VP-CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 7,850 | 0 | - | - | Stock Option | |
| AAR Corp | Eric S. Pachapa | VP-CAO & Controller | Sale of securities on an exchange or to another person at price $ 54.74 per share. | 29 Mar 2023 | 7,850 | 27,416 (0%) | 0% | 54.7 | 429,718 | Common Stock |
| Etsy Inc | Joshua G. Silverman | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 106.70 per share. | 29 Mar 2023 | 7,759 | 108,199 (0%) | 0% | 106.7 | 827,885 | Common Stock |
| Roblox Corp (Class A) | Gregory Baszucki | Director | Sale of securities on an exchange or to another person at price $ 42.73 per share. | 29 Mar 2023 | 7,327 | 9,897,942 | - | 42.7 | 313,087 | Class A Common Stock |
| Healthequity Inc | Tyson Murdock | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 7,261 | 79,598 (0%) | 0% | 0 | Common Stock | |
| Winnebago Ind Inc | Christopher David West | SVP-OPERATIONS | Sale of securities on an exchange or to another person at price $ 56.61 per share. | 29 Mar 2023 | 7,210 | 25,383 (0%) | 0% | 56.6 | 408,158 | Common Stock, $.50 par value |
| Alignment Healthcare Inc | Dawn Maroney | President, Markets | Sale of securities on an exchange or to another person at price $ 6.11 per share. | 29 Mar 2023 | 7,178 | 1,929,308 | - | 6.1 | 43,881 | Common Stock |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 149.99 per share. | 29 Mar 2023 | 7,156 | 5,411,946 (1%) | 0% | 150.0 | 1,073,328 | Common Stock |
| Gogo Inc | Jessica G. Betjemann | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 7,139 | 58,940 (0%) | 0% | - | Common Stock | |
| Gogo Inc | Jessica G. Betjemann | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 7,139 | 14,278 | - | - | Restricted Stock Units | |
| Legacy Housing Corp | Kenneth E. Shipley | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 21.75 per share. | 29 Mar 2023 | 7,000 | 3,054,667 (12%) | 0% | 21.8 | 152,250 | Common Stock, par value $0.001 per share ("Common Stock") |
| QuinStreet Inc | Douglas Valenti | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Mar 2023 | 7,000 | 1,758,517 (3%) | 0% | 0 | Common Stock | |
| PTC | Blake D. Moret | Director | Sale of securities on an exchange or to another person at price $ 124.66 per share. | 29 Mar 2023 | 6,824 | 7,175,832 (6%) | 0% | 124.7 | 850,689 | Common Stock |
| Main Street Cap Corp | Jason B. Beauvais | EVP, GC, CCO, SECRETARY | Sale of securities on an exchange or to another person at price $ 39.40 per share. | 29 Mar 2023 | 6,800 | 160,037 (0%) | 0% | 39.4 | 267,954 | Common Stock |
| Southwest Gas Holdings Inc | Robert J. Stefani | SVP/Chief Financial Officer | 29 Mar 2023 | 6,755 | 38,103 (0%) | 0% | 0 | Common Stock | ||
| Jefferies Fin Grp Inc | Barry J. Alperin | Director | Grant, award, or other acquisition of securities at price $ 31.14 per share. | 29 Mar 2023 | 6,583 | 53,137 (0%) | 0% | 31.1 | 204,995 | Common Stock |
| Jefferies Fin Grp Inc | O Michael T Kane | Director | Grant, award, or other acquisition of securities at price $ 31.14 per share. | 29 Mar 2023 | 6,583 | 111,869 (0%) | 0% | 31.1 | 204,995 | Common Stock |
| Jefferies Fin Grp Inc | Robert D. Beyer | Director | Grant, award, or other acquisition of securities at price $ 31.14 per share. | 29 Mar 2023 | 6,583 | 139,619 (0%) | 0% | 31.1 | 204,995 | Common Stock |
| Jefferies Fin Grp Inc | Thomas W. Jones | Director | Grant, award, or other acquisition of securities at price $ 31.14 per share. | 29 Mar 2023 | 6,583 | 62,545 (0%) | 0% | 31.1 | 204,995 | Common Stock |
| Jefferies Fin Grp Inc | Linda L. Adamany | Director | Grant, award, or other acquisition of securities at price $ 31.14 per share. | 29 Mar 2023 | 6,583 | 70,603 (0%) | 0% | 31.1 | 204,995 | Common Stock |
| Jefferies Fin Grp Inc | Jacob M. Katz | Director | Grant, award, or other acquisition of securities at price $ 31.14 per share. | 29 Mar 2023 | 6,583 | 43,137 (0%) | 0% | 31.1 | 204,995 | Common Stock |
| Jefferies Fin Grp Inc | MaryAnne Gilmartin | Director | Grant, award, or other acquisition of securities at price $ 31.14 per share. | 29 Mar 2023 | 6,583 | 43,137 (0%) | 0% | 31.1 | 204,995 | Common Stock |
| Jefferies Fin Grp Inc | Melissa V. Weiler | Director | Grant, award, or other acquisition of securities at price $ 31.14 per share. | 29 Mar 2023 | 6,583 | 24,683 (0%) | 0% | 31.1 | 204,995 | Common Stock |
| Jefferies Fin Grp Inc | Matrice Ellis Kirk | Director | Grant, award, or other acquisition of securities at price $ 31.14 per share. | 29 Mar 2023 | 6,583 | 16,683 (0%) | 0% | 31.1 | 204,995 | Common Stock |
| Innovative Soln And Support Inc | Christopher Harborne | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.50 per share. | 29 Mar 2023 | 6,506 | 2,609,769 (15%) | 0% | 7.5 | 48,795 | Common Stock, par value $0.001 per share |
| Cns Pharma Inc | Christopher Downs | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 6,067 | 28,768 | - | - | Restricted Stock Units | |
| Main Street Cap Corp | Jason B. Beauvais | EVP, GC, CCO, SECRETARY | Sale of securities on an exchange or to another person at price $ 39.45 per share. | 29 Mar 2023 | 5,894 | 151,918 (0%) | 0% | 39.5 | 232,532 | Common Stock |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 226.16 per share. | 29 Mar 2023 | 5,832 | 2,988,866 (5%) | 0% | 226.2 | 1,318,977 | Common Stock |
| Southwest Gas Holdings Inc | Justin L. Brown | President/Southwest Gas Corp. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 5,659 | 17,173 (0%) | 0% | 0 | Common Stock | |
| Bumble Inc (Class A) | Anuradha B. Subramanian | Chief Financial Officer | 29 Mar 2023 | 5,408 | 129,022 | - | 20.1 | 108,701 | Class A Common Stock | |
| Alignment Healthcare Inc | Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.11 per share. | 29 Mar 2023 | 5,312 | 712,666 | - | 6.1 | 32,474 | Common Stock |
| CRISPR Therapeutics AG | Samarth Kulkarni | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 44.78 per share. | 29 Mar 2023 | 5,281 | 387,377 (0%) | 0% | 44.8 | 236,506 | Common Shares |
| Middlesex Water Co. | Dennis W. Doll | Director, President & CEO | 29 Mar 2023 | 5,153 | 28,746 | - | 77.6 | 400,027 | Common Stock (Restricted Stock Book Entry) | |
| Gamestop Corp (Class A) | Lawrence Cheng | Director | Purchase of securities on an exchange or from another person at price $ 22.80 per share. | 29 Mar 2023 | 5,000 | 37,088 (0%) | 0% | 22.8 | 113,990 | Class A Common Stock |
| LeonaBio Inc | James A. Johnson | Director | Purchase of securities on an exchange or from another person at price $ 2.40 per share. | 29 Mar 2023 | 5,000 | 5,000 | - | 2.4 | 12,000 | Common Stock |
| CytomX Therapeutics Inc | Jones V Elaine | Director | Purchase of securities on an exchange or from another person at price $ 1.55 per share. | 29 Mar 2023 | 5,000 | 5,142 (0%) | 0% | 1.6 | 7,750 | Common Stock |
| eXp World Holdings Inc | Courtney Keating Chakarun | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.99 per share. | 29 Mar 2023 | 5,000 | 5,000 (0%) | 0% | 6.0 | 29,950 | Common Stock |
| eXp World Holdings Inc | Courtney Keating Chakarun | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 5,000 | 147,500 | - | - | Stock Options (Right to buy) | |
| eXp World Holdings Inc | Courtney Keating Chakarun | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 12.11 per share. | 29 Mar 2023 | 5,000 | 0 (0%) | 0% | 12.1 | 60,529 | Common Stock |
| Intapp Inc | Don Coleman | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 44.06 per share. | 29 Mar 2023 | 5,000 | 506,425 | - | 44.1 | 220,288 | Common Stock |
| Intapp Inc | Don Coleman | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 5,000 | 545,600 | - | - | Employee Stock Option (right to buy) | |
| Intapp Inc | Don Coleman | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.99 per share. | 29 Mar 2023 | 5,000 | 511,425 | - | 4.0 | 19,950 | Common Stock |
| Prothena Corporation plc | Michael J. Malecek | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 5,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Michael J. Malecek | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.27 per share. | 29 Mar 2023 | 5,000 | 5,000 (0%) | 0% | 10.3 | 51,350 | Ordinary Shares, par value $0.01 per share |
| TELA Bio Inc | Vincent J. Burgess | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 4,860 | 0 | - | - | Stock Option (Right to Buy) | |
| TELA Bio Inc | Vincent J. Burgess | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.44 per share. | 29 Mar 2023 | 4,860 | 7,995 (0%) | 0% | 4.4 | 21,578 | Common Stock |
| Dollar General | Michael M. Calbert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 4,839 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Dollar General | Michael M. Calbert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.50 per share. | 29 Mar 2023 | 4,839 | 113,240 (0%) | 0% | 53.5 | 258,887 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.45 per share. | 29 Mar 2023 | 4,688 | 42,747 (0%) | 0% | 40.5 | 189,630 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 4,688 | 0 | - | - | Stock Option (Right to Buy) | |
| Xponential Fitness Inc (Class A) | Anthony Geisler | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Mar 2023 | 4,583 | 14,622 | - | 0 | Class B Common Stock | |
| Xponential Fitness Inc (Class A) | Anthony Geisler | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Mar 2023 | 4,583 | 14,622 | - | - | LLC Units in Xponential Holdings LLC | |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 157.29 per share. | 29 Mar 2023 | 4,522 | 21,320 (0%) | 0% | 157.3 | 711,277 | Class A Common Stock |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 157.29 per share. | 29 Mar 2023 | 4,521 | 20,055 (0%) | 0% | 157.3 | 711,119 | Class A Common Stock |
| John Wiley & Sons Inc (Class A) | H. | EVP & GM, APL | Sale of securities on an exchange or to another person at price $ 37.28 per share. | 29 Mar 2023 | 4,500 | 5,184 (0%) | 0% | 37.3 | 167,760 | Class A Common |
| McCormick & Company | Margaret M.V. Preston | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.14 per share. | 29 Mar 2023 | 4,413 | 95,023 (1%) | 0% | 81.1 | 358,071 | Common Stock - Voting |
| McCormick & Company | Margaret M.V. Preston | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.14 per share. | 29 Mar 2023 | 4,413 | 91,023 (0%) | 0% | 81.1 | 358,071 | Common Stock - Voting |
| Middlesex Water Co. | Dennis W. Doll | Director, President & CEO | 29 Mar 2023 | 4,319 | 4,319 (0%) | 0% | 77.6 | 335,284 | Common Stock (Book Entry) | |
| Assembly Biosciences Inc | Jason A. Okazaki | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 0.82 per share. | 29 Mar 2023 | 4,247 | 98,174 (0%) | 0% | 0.8 | 3,496 | Common Stock |
| Principal Financial Group | Roberto A. Walker | EVP, Principal Latin American | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 4,112 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Principal Financial Group | Roberto A. Walker | EVP, Principal Latin American | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 4,112 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Principal Financial Group | Roberto A. Walker | EVP, Principal Latin American | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 4,111 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Ampco-Pittsburgh Corp | David George Anderson | President,Air&Liq. Proc. Group | Purchase of securities on an exchange or from another person at price $ 2.45 per share. | 29 Mar 2023 | 4,100 | 29,420 (0%) | 0% | 2.5 | 10,045 | Common Stock |
| Bumble Inc (Class A) | Tariq M. Shaukat | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.10 per share. | 29 Mar 2023 | 4,084 | 184,897 | - | 20.1 | 82,088 | Class A Common Stock |
| Bumble Inc (Class A) | Laura Franco | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.10 per share. | 29 Mar 2023 | 4,055 | 155,680 | - | 20.1 | 81,506 | Class A Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, CHAIRPERSON & CEO | Sale of securities on an exchange or to another person at price $ 217.06 per share. | 29 Mar 2023 | 4,027 | 4,103 (0%) | 0% | 217.1 | 874,089 | Common Stock |
| Lument Finance Trust Inc | Walter C. Keenan | Director | Purchase of securities on an exchange or from another person at price $ 2.06 per share. | 29 Mar 2023 | 4,000 | 109,944 (0%) | 0% | 2.1 | 8,240 | common stock |
| iRhythm Tech Inc | Daniel G. Wilson | EVP, Corp Dev Inv Rel | Sale of securities on an exchange or to another person at price $ 125.00 per share. | 29 Mar 2023 | 4,000 | 35,337 (0%) | 0% | 125 | 500,000 | Common Stock |
| Dollar General | Michael M. Calbert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.93 per share. | 29 Mar 2023 | 3,994 | 108,401 (0%) | 0% | 53.9 | 215,396 | Common Stock |
| Dollar General | Michael M. Calbert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 3,994 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| J.Jill Inc | James S. Scully | Director | 29 Mar 2023 | 3,790 | 3,790 | - | - | Restricted Stock Units | ||
| J.Jill Inc | Shelley B. Milano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,790 | 3,790 | - | - | Restricted Stock Units | |
| J.Jill Inc | Michael M Rahamim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,790 | 3,790 | - | - | Restricted Stock Units | |
| J.Jill Inc | Michael A. Eck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,790 | 3,790 | - | - | Restricted Stock Units | |
| J.Jill Inc | Andrew Rolfe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,790 | 3,790 | - | - | Restricted Stock Units | |
| J.Jill Inc | Jyothi Rao | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,790 | 3,790 | - | - | Restricted Stock Units | |
| Gogo Inc | Karen Jackson | EVP, Chief People Exp. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.98 per share. | 29 Mar 2023 | 3,789 | 119,356 (0%) | 0% | 14.0 | 52,970 | Common Stock |
| Principal Financial Group | Roberto A. Walker | EVP, Principal Latin American | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 3,744 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Kaltura Inc | Yaron Garmazi | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.82 per share. | 29 Mar 2023 | 3,739 | 1,026,565 | - | 1.8 | 6,793 | Common Stock |
| Nature`s Sunshine Products Inc | Terrence O. Moorehead | Director, Chief Executive Officer | 29 Mar 2023 | 3,718 | 442,207 (2%) | 0% | 10.5 | 38,927 | Common Shares | |
| VerifyMe Inc | Adam H. Stedham | Director | Purchase of securities on an exchange or from another person at price $ 1.58 per share. | 29 Mar 2023 | 3,700 | 50,287 | - | 1.6 | 5,846 | Common Stock, par value $0.001 |
| United Therapeutics Corp | Martine A. Rothblatt | Director, CHAIRPERSON & CEO | Sale of securities on an exchange or to another person at price $ 217.96 per share. | 29 Mar 2023 | 3,606 | 497 (0%) | 0% | 218.0 | 785,970 | Common Stock |
| J.Jill Inc | Kyle Polischuk | SVP CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,516 | 3,516 | - | - | Restricted Stock Units | |
| J.Jill Inc | Kyle Polischuk | SVP CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,514 | 3,514 | - | - | Performance Stock Units | |
| AAR Corp | Eric S. Pachapa | VP-CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 3,500 | 19,520 | - | - | Stock Option | |
| AAR Corp | Eric S. Pachapa | VP-CAO & Controller | Sale of securities on an exchange or to another person at price $ 54.74 per share. | 29 Mar 2023 | 3,500 | 27,416 (0%) | 0% | 54.7 | 191,594 | Common Stock |
| AAR Corp | Eric S. Pachapa | VP-CAO & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.94 per share. | 29 Mar 2023 | 3,500 | 30,916 (0%) | 0% | 18.9 | 66,290 | Common Stock |
| Assembly Biosciences Inc | William E. Delaney | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 0.82 per share. | 29 Mar 2023 | 3,421 | 85,498 (0%) | 0% | 0.8 | 2,816 | Common Stock |
| US Foods Holding Corp | Steven M. Guberman | EVP, Nationally Managed Bus. | Sale of securities on an exchange or to another person at price $ 36.60 per share. | 29 Mar 2023 | 3,412 | 99,090 (0%) | 0% | 36.6 | 124,879 | Common Stock |
| Clearwater Analytics Holdings Inc (Class A) | Kathleen A. Corbet | Director | 29 Mar 2023 | 3,405 | 3,405 | - | - | Restricted Stock Unit | ||
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 226.16 per share. | 29 Mar 2023 | 3,340 | 2,985,526 (5%) | 0% | 226.2 | 755,381 | Common Stock |
| GlycoMimetics Inc | Rachel K. King | Director | 29 Mar 2023 | 3,334 | 515,194 (1%) | 0% | 3 | 10,002 | Common Stock | |
| Clearwater Analytics Holdings Inc (Class A) | Jacques Aigrain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,320 | 3,320 | - | - | Restricted Stock Unit | |
| Alignment Healthcare Inc | Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.26 per share. | 29 Mar 2023 | 3,290 | 709,376 | - | 6.3 | 20,608 | Common Stock |
| Alignment Healthcare Inc | Dinesh Kumar | Chief Med & Operating Officer | Sale of securities on an exchange or to another person at price $ 6.11 per share. | 29 Mar 2023 | 3,286 | 1,088,651 | - | 6.1 | 20,088 | Common Stock |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Sale of securities on an exchange or to another person at price $ 47.80 per share. | 29 Mar 2023 | 3,247 | 39,500 (0%) | 0% | 47.8 | 155,200 | Common Stock |
| McCormick & Company | Gregory P. Repas | V.P. & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,230 | 3,230 | - | - | Options - Right to Buy | |
| McCormick & Company | Freeman A. Hrabowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,101 | 3,101 | - | - | Options - Right to Buy | |
| McCormick & Company | Gary M. Rodkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,101 | 3,101 | - | - | Options- Right to Buy | |
| McCormick & Company | Margaret M.V. Preston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,101 | 3,101 | - | - | Options - Right to Buy | |
| McCormick & Company | Patricia A. Little | Director | 29 Mar 2023 | 3,101 | 3,101 | - | - | Options- Right to Buy | ||
| McCormick & Company | Michael D. Mangan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,101 | 3,101 | - | - | Options- Right to Buy | |
| McCormick & Company | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,101 | 3,101 | - | - | Options- Right to Buy | |
| McCormick & Company | Jacques Tapiero | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,101 | 3,101 | - | - | Options - Right to Buy | |
| McCormick & Company | Anne L. Bramman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,101 | 3,101 | - | - | Options- Right to Buy | |
| McCormick & Company | Maritza Gomez Montiel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,101 | 3,101 | - | - | Options- Right to Buy | |
| McCormick & Company | Michael A. Conway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,101 | 3,101 | - | - | Options- Right to Buy | |
| Ardelyx Inc | David P. Rosenbaum | Chief Development Officer | 29 Mar 2023 | 3,000 | 113,096 (0%) | 0% | 4.6 | 13,888 | Common Stock | |
| RMR Grp Inc (Class A) | Jennifer B. Clark | Director, MD, Exec. VP, GC & Secty | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,000 | 42,416 (0%) | 0% | - | Class A Common Stock | |
| RMR Grp Inc (Class A) | Ann D. Logan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,000 | 23,578 (0%) | 0% | - | Class A Common Stock | |
| RMR Grp Inc (Class A) | Adam D. Portnoy | Director, Managing Dir., President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,000 | 97,938 (0%) | 0% | - | Class A Common Stock | |
| RMR Grp Inc (Class A) | Walter C. Watkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,000 | 21,000 (0%) | 0% | - | Class A Common Stock | |
| RMR Grp Inc (Class A) | Rosen Plevneliev | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,000 | 17,025 (0%) | 0% | - | Class A Common Stock | |
| RMR Grp Inc (Class A) | Jonathan Veitch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 3,000 | 12,000 (0%) | 0% | - | Class A Common Stock | |
| Trade Desk Inc (Class A) | Gokul Rajaram | Director | Sale of securities on an exchange or to another person at price $ 59.40 per share. | 29 Mar 2023 | 2,999 | 74,059 (0%) | 0% | 59.4 | 178,141 | Class A Common Stock |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 148.24 per share. | 29 Mar 2023 | 2,979 | 5,435,067 (1%) | 0% | 148.2 | 441,607 | Common Stock |
| Claritev Corp (Class A) | Gerald J. Kozel | SVP, Chief Accounting Officer | 29 Mar 2023 | 2,958 | 838,227 | - | 1.1 | 3,195 | Class A common stock | |
| CompoSecure Inc (Class A) | Donald G. Basile | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 Mar 2023 | 2,912 | 10,514,788 | - | - | Warrant | |
| CompoSecure Inc (Class A) | Dixon R. Doll | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 29 Mar 2023 | 2,912 | 10,514,788 | - | - | Warrant | |
| Southwest Gas Holdings Inc | Julie M. Williams | SVP/Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 2,873 | 15,385 (0%) | 0% | 0 | Common Stock | |
| Middlesex Water Co. | A. Bruce O'Connor | Sr. Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.63 per share. | 29 Mar 2023 | 2,825 | 9,440 | - | 77.6 | 219,305 | Common Stock (Restricted Stock Book Entry) |
| Southwest Gas Holdings Inc | Randall P. Gabe | SVP/Chief Administrative OFC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 2,817 | 13,046 (0%) | 0% | 0 | Common Stock | |
| Claritev Corp (Class A) | Jeffrey A. Doctoroff | EVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.08 per share. | 29 Mar 2023 | 2,780 | 1,241,599 | - | 1.1 | 3,002 | Class A common stock |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 227.04 per share. | 29 Mar 2023 | 2,757 | 2,982,769 (5%) | 0% | 227.0 | 625,958 | Common Stock |
| US Foods Holding Corp | Steven M. Guberman | EVP, Nationally Managed Bus. | Sale of securities on an exchange or to another person at price $ 36.54 per share. | 29 Mar 2023 | 2,735 | 94,579 (0%) | 0% | 36.5 | 99,937 | Common Stock |
| Prothena Corporation plc | Michael J. Malecek | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 48.81 per share. | 29 Mar 2023 | 2,734 | 2,266 (0%) | 0% | 48.8 | 133,456 | Ordinary Shares, par value $0.01 per share |
| US Foods Holding Corp | Andrew E. Iacobucci | See Remarks | Sale of securities on an exchange or to another person at price $ 36.60 per share. | 29 Mar 2023 | 2,728 | 190,020 (0%) | 0% | 36.6 | 99,845 | Common Stock |
| AutoZone | William R. Hackney | Sr. Vice President | 29 Mar 2023 | 2,724 | 2,724 (0%) | 0% | 772.8 | 2,105,107 | Common Stock | |
| AutoZone | William R. Hackney | Sr. Vice President | 29 Mar 2023 | 2,724 | 0 (0%) | 0% | 2394.5 | 6,522,482 | Common Stock | |
| AutoZone | William R. Hackney | Sr. Vice President | 29 Mar 2023 | 2,724 | 0 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 158.47 per share. | 29 Mar 2023 | 2,586 | 17,228 (0%) | 0% | 158.5 | 409,793 | Class A Common Stock |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Co-CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 158.47 per share. | 29 Mar 2023 | 2,586 | 17,468 (0%) | 0% | 158.5 | 409,793 | Class A Common Stock |
| Privia Health Group Inc | Parth Mehrotra | President and COO | Sale of securities on an exchange or to another person at price $ 28.01 per share. | 29 Mar 2023 | 2,554 | 97,391 | - | 28.0 | 71,538 | Common Stock, $0.01 par value per share |
| Privia Health Group Inc | Parth Mehrotra | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 2,554 | 258,316 | - | - | Stock Option (Right to Purchase) | |
| Privia Health Group Inc | Parth Mehrotra | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. | 29 Mar 2023 | 2,554 | 99,945 | - | 2 | 5,108 | Common Stock, $0.01 par value per share |
| Five9 Inc | Barry Zwarenstein | Chief Financial Officer | 29 Mar 2023 | 2,500 | 109,803 (0%) | 0% | 65.1 | 162,650 | Common Stock | |
| Five9 Inc | Barry Zwarenstein | Chief Financial Officer | 29 Mar 2023 | 2,500 | 107,303 (0%) | 0% | 70.1 | 175,200 | Common Stock | |
| Rhythm Pharma Inc | William T. Roberts | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 2,500 | 8,784 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | William T. Roberts | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 2,500 | 5,000 | - | - | Restricted Stock Units | |
| US Foods Holding Corp | Andrew E. Iacobucci | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.29 per share. | 29 Mar 2023 | 2,498 | 187,522 (0%) | 0% | 36.3 | 90,652 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, CHAIRPERSON & CEO | Sale of securities on an exchange or to another person at price $ 217.89 per share. | 29 Mar 2023 | 2,447 | 1,765 (0%) | 0% | 217.9 | 533,184 | Common Stock |
| Tyra Biosciences Inc | Todd Harris | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 2,407 | 400,037 | - | - | Stock Option (Right to Buy) | |
| Tyra Biosciences Inc | Todd Harris | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.02 per share. | 29 Mar 2023 | 2,407 | 1,701,276 | - | 16.0 | 38,552 | Common Stock |
| Tyra Biosciences Inc | Todd Harris | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.25 per share. | 29 Mar 2023 | 2,407 | 1,703,683 | - | 2.3 | 5,416 | Common Stock |
| Perma-Fix Environmental Services Inc | Joe. R. Reeder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 2,400 | 0 | - | - | Stock Option (Right to Buy) | |
| Perma-Fix Environmental Services Inc | Joe. R. Reeder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.78 per share. | 29 Mar 2023 | 2,400 | 227,183 (1%) | 0% | 2.8 | 6,684 | Common Stock |
| Middlesex Water Co. | A. Bruce O'Connor | Sr. Vice President & CFO | Other type of transaction at price $ 77.63 per share. | 29 Mar 2023 | 2,319 | 11,759 | - | 77.6 | 180,024 | Common Stock (Restricted Stock Book Entry) |
| US Foods Holding Corp | Andrew E. Iacobucci | See Remarks | Sale of securities on an exchange or to another person at price $ 36.54 per share. | 29 Mar 2023 | 2,278 | 185,244 (0%) | 0% | 36.5 | 83,238 | Common Stock |
| Prothena Corporation plc | Michael J. Malecek | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 49.28 per share. | 29 Mar 2023 | 2,266 | 0 (0%) | 0% | 49.3 | 111,667 | Ordinary Shares, par value $0.01 per share |
| Main Street Cap Corp | Jason B. Beauvais | EVP, GC, CCO, SECRETARY | Sale of securities on an exchange or to another person at price $ 39.53 per share. | 29 Mar 2023 | 2,225 | 157,812 (0%) | 0% | 39.5 | 87,954 | Common Stock |
| Mattel Inc | Noreena Hertz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 2,208 | 2,208 | - | - | Restricted Stock Units |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.